Strong Gametocytocidal Effect of Methylene Blue-Based Combination Therapy against Falciparum Malaria: A Randomised Controlled Trial
Boubacar Coulibaly, Augustin Zoungrana, Frank P. Mockenhaupt et al. · 2009
Read Strong Gametocytocidal Effect of Methylene Blue-Based Combination Therapy against Falciparum Malaria: A Randomised Controlled Trial by Boubacar Coulibaly, Augustin Zoungrana, Frank P. Mockenhaupt et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0005318.txt.
Description
Controlling malaria means not only curing patients but also stopping spread to mosquitoes. Drugs that kill the parasite's sexual stages, called gametocytes, can break transmission. Coulibaly and colleagues ran a randomized controlled trial of a methylene blue combination therapy in PLOS ONE in 2009.
Methylene blue is an old, blue-dyed drug with activity against malaria parasites. The trial found a strong gametocytocidal effect, as the title states, against falciparum malaria. A transmission-blocking treatment like this could support local elimination of malaria, not just treatment of the sick. A drug that stops spread, not just cures the sick, could help a town clear malaria for good. Since each cured case would no longer seed new ones by mosquito bite.
Catalog record
| CREATOR | Boubacar Coulibaly, Augustin Zoungrana, Frank P. Mockenhaupt et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0005318